An Overview of Recent Advances in the Synthesis and Applications of the Transition Metal Carbide Nanomaterials.

Good stability and reproducibility are important factors in determining the place of any material in their respective field and these two factors also enable them to use in various applications. At present, transition metal carbides (TMCs) have high demand either in the two-dimensional (2D) form (MXene) or as nanocomposites, nanoparticles, carbide films, carbide nano-powder, and carbide nanofibers. They have shown good stability at high temperatures in different environments and also have the ability to show adequate reproducibility. Metal carbides have shown a broad spectrum of properties enabling them to engage the modern approach of multifacet material. Several ways have been routed to synthesize metal carbides in their various forms but few of those gain more attention due to their easy approach and better properties. TMCs find applications in various fields, such as catalysts, absorbents, bio-sensors, pesticides, electrogenerated chemiluminescence (ECL), anti-pollution and anti-bacterial agents, and in tumor detection. This article highlights some recent developments in the synthesis methods and applications of TMCs in various fields.

A novel TSC1 variant associated with tuberous sclerosis and sacrococcygeal teratoma.

Tuberous sclerosis complex (TSC) is an autosomal dominant disease associated with tumors and malformed tissues in the brain and other vital organs. We report a novel de novo frameshift variant of the TSC1 gene (c.434dup;p. Ser146Valfs*8) in a child with TSC who initially presented with a sacral teratoma. This previously unreported association between TSC and teratoma has broad implications for the pathophysiology of embryonic tumors and mechanisms underlying cellular differentiation.

Design and Parameter Study of Integrated Microfluidic Platform for CTC Isolation and Enquiry; A Numerical Approach.

Being the second cause of mortality across the globe, there is now a persistent effort to establish new cancer medication and therapies. Any accomplishment in treating cancers entails the existence of accurate identification systems empowering the early diagnosis. Recent studies indicate CTCs’ potential in cancer prognosis as well as therapy monitoring. The chief shortcoming with CTCs is that they are exceedingly rare cells in their clinically relevant concentration. Here, we simulated a microfluidic construct devised for immunomagnetic separation of the particles of interest from the background cells. This separation unit is integrated with a mixer subunit. The mixer is envisioned for mixing the CTC enriched stream with lysis buffer to extract the biological material of the cell. Some modification was proposed on mixing geometry improving the efficacy of the functional unit. A valuation of engaged forces was made and some forces were neglected due to their order of magnitude. The position of the magnet was also optimized by doing parametric study. For the mixer unit, the effect of applied voltage and frequency on mixing index was studied to find the optimal voltage and frequency which provides better mixing. Above-mentioned studies were done on isolated units and the effect of each functional unit on the other is not studied. As the final step, an integrated microfluidic platform composed of both functional subunits was simulated simultaneously. To ensure the independence of results from the grid, grid studies were also performed. The studies carried out on the construct reveal its potential for diagnostic application.

N-Ethyl-4-methyl-N-(3-methyl-phen-yl)benzene-sulfonamide.

The title compound, C(16)H(19)NO(2)S, crystallizes with two crystallographically independent mol-ecules in the asymmetric unit in which the dihedral angles between the planes defined by the aromatic rings are 35.3 (2) and 42.5 (2)°. In the crystal, inter-molecular C-H⋯O hydrogen bonds stabilize the packing.

N-Benzyl-4-methyl-N-(4-methyl-phen-yl)benzene-sulfonamide.

In the title mol-ecule, C(21)H(21)NO(2)S, the phenyl ring makes the dihedral angles of 74.13 (11) and 80.16 (11)° with the two benzene rings, which are inclined at an angle of 43.73 (10)° with respect to each other. In the crystal, mol-ecules are linked by inter-molecular C-H⋯O hydrogen bonds along the [010] direction. In addition, a weak C-H⋯π (arene) inter-action is observed.

Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents.

OBJECTIVE: To report the clinical features of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in patients < or = 18 years old. METHODS: Information was obtained by the authors or referring physicians. Antibodies were determined by immunocytochemistry and enzyme-linked immunosorbent assay (ELISA) using HEK293 cells ectopically expressing NR1. RESULTS: Over an 8-month period, 81 patients (12 male) with anti-NMDAR encephalitis were identified. Thirty-two (40%) were < or =18 years old (youngest 23 months, median 14 years); 6 were male. The frequency of ovarian teratomas was 56% in women >18 years old, 31% in girls < or =18 years old (p = 0.05), and 9% in girls < or =14 years old (p = 0.008). None of the male patients had tumors. Of 32 patients < or =18 years old, 87.5% presented with behavioral or personality change, sometimes associated with seizures and frequent sleep dysfunction; 9.5% with dyskinesias or dystonia; and 3% with speech reduction. On admission, 53% had severe speech deficits. Eventually, 77% developed seizures, 84% stereotyped movements, 86% autonomic instability, and 23% hypoventilation. Responses to immunotherapy were slow and variable. Overall, 74% had full or substantial recovery after immunotherapy or tumor removal. Neurological relapses occurred in 25%. At the last follow-up, full recovery occurred more frequently in patients who had a teratoma that was removed (5/8) than in those without a teratoma (4/23; p = 0.03). INTERPRETATION: Anti-NMDAR encephalitis is increasingly recognized in children, comprising 40% of all cases. Younger patients are less likely to have tumors. Behavioral and speech problems, seizures, and abnormal movements are common early symptoms. The phenotype resembles that of the adults, although dysautonomia and hypoventilation are less frequent or severe in children. Ann Neurol 2009;66:11-18.